Oculeve was a start-up consumer/med. tech. company with a first-in-class connected health technology to address an unmet clinical need in ophthalmology. Early investors included KPCB, NEA, and Versant. In August 2015, Oculeve was acquired by Allergan Plc.

Patents 113show all

  • 19
    A61N - Electrotherapy
  • 5
    B29D - Producing particular articles from plastics or from substances in a plastic state

Clinical Trials 11show all

7N/A3Phase 21Phase 1/Phase 2

SEC Filings show all


4
D

Contact Information

395 Oyster Point Suite 501
San Francisco, CA 94080
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$32,305,47311-502014-03-16Acquired

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2014-03-16$16,649,997Series Unknown
2012-10-01$7,565,000Series UnknownKleiner Perkins, New Enterprise Associates (NEA)
2013-03-21$7,590,476Series Unknown
2012-05-14$500,000Debt Financing

SEC Form D Funding Events

DateOfferedSoldType
2014-03-18$16,649,997$16,649,997Equity
2013-03-20$7,592,976$7,590,476Equity
2012-08-30$700,000$700,000Debt, Option to Acquire, Security to be Acquired
2012-05-14$500,000$500,000Debt, Option to Acquire, Security to be Acquired

Key Executives

  • D. Michael Ackermann, PhD
    Executive Officer, Director
  • Ali Behbahani
    Director
  • William Link
    Director
  • Brook Byers
    Director
  • Mark Blumenkranz
    Director
  • Mark S. Blumenkranz, MD
    Director
  • William J. Link, PhD
    Director
  • Steve Waite
    Director
  • James Loudin
    Executive Officer